Efficacy and safety of switching from Eculizumab to Ravulizumab for the maintenance of aHUS remission after kidney transplant: a preliminary experience

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: 1 Online-Ressource.

Language: Englisch

Bibliographic citation: Efficacy and safety of switching from Eculizumab to Ravulizumab for the maintenance of aHUS remission after kidney transplant: a preliminary experience ; day:16 ; month:7 ; year:2024 ; pages:1-3
Journal of nephrology ; (16.7.2024), 1-3

Creator: Busutti, Marco
Maritati, Federica
Borelli, Greta
Bini, Claudia
Corradetti, Valeria
Cuna, Vania
Abenavoli, Chiara
Provenzano, Michele
Ravaioli, Matteo
La Manna, Gaetano
Comai, Giorgia

Contributor: SpringerLink (Online service)

DOI: 10.1007/s40620-024-02005-7

URN: urn:nbn:de:101:1-2410090958272.122091369983

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:24 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Busutti, Marco
Maritati, Federica
Borelli, Greta
Bini, Claudia
Corradetti, Valeria
Cuna, Vania
Abenavoli, Chiara
Provenzano, Michele
Ravaioli, Matteo
La Manna, Gaetano
Comai, Giorgia
SpringerLink (Online service)

Other Objects (12)

Eculizumab treatment in paediatric patients diagnosed with aHUS after haematopoietic stem cell transplantation: a HSCT-TMA case series from Japanese aHUS post-marketing surveillance

Functional similarity of ABP 959 and eculizumab in simulated serum models of aHUS and NMOSD

Pregnancy-triggered atypical hemolytic uremic syndrome (aHUS): a Global aHUS Registry analysis

Clinical efficacy and safety of switching from eculizumab to ravulizumab in adult patients with aHUS– real-world data

The global aHUS registry: methodology and initial patient characteristics

Schriftgut

Ahus

Schriftgut

Ahus

Charakterisierung von Patienten mit atypischem hämolytisch-urämischen Syndrom (aHUS) in Deutschland : Daten aus dem globalen aHUS-Register

Outcomes following second allogeneic stem cell transplant for disease relapse after T cell depleted transplant correlate with remission status and remission duration after the first transplant

Treating C3 glomerulopathy with eculizumab

Eculizumab treatment in paediatric patients diagnosed with aHUS after haematopoietic stem cell transplantation: a HSCT-TMA case series from Japanese aHUS post-marketing surveillance

Functional similarity of ABP 959 and eculizumab in simulated serum models of aHUS and NMOSD

Pregnancy-triggered atypical hemolytic uremic syndrome (aHUS): a Global aHUS Registry analysis

Clinical efficacy and safety of switching from eculizumab to ravulizumab in adult patients with aHUS– real-world data

The global aHUS registry: methodology and initial patient characteristics

Schriftgut

Ahus

Schriftgut

Ahus

Charakterisierung von Patienten mit atypischem hämolytisch-urämischen Syndrom (aHUS) in Deutschland : Daten aus dem globalen aHUS-Register

Outcomes following second allogeneic stem cell transplant for disease relapse after T cell depleted transplant correlate with remission status and remission duration after the first transplant

Treating C3 glomerulopathy with eculizumab

Eculizumab treatment in paediatric patients diagnosed with aHUS after haematopoietic stem cell transplantation: a HSCT-TMA case series from Japanese aHUS post-marketing surveillance

Functional similarity of ABP 959 and eculizumab in simulated serum models of aHUS and NMOSD

Pregnancy-triggered atypical hemolytic uremic syndrome (aHUS): a Global aHUS Registry analysis

Clinical efficacy and safety of switching from eculizumab to ravulizumab in adult patients with aHUS– real-world data

The global aHUS registry: methodology and initial patient characteristics

Schriftgut

Ahus

Schriftgut

Ahus

Charakterisierung von Patienten mit atypischem hämolytisch-urämischen Syndrom (aHUS) in Deutschland : Daten aus dem globalen aHUS-Register

Outcomes following second allogeneic stem cell transplant for disease relapse after T cell depleted transplant correlate with remission status and remission duration after the first transplant

Treating C3 glomerulopathy with eculizumab

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Efficacy and safety of switching from Eculizumab to Ravulizumab for the maintenance of aHUS remission after kidney transplant: a preliminary experience

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Eculizumab treatment in paediatric patients diagnosed with aHUS after haematopoietic stem cell transplantation: a HSCT-TMA case series from Japanese aHUS post-marketing surveillance

Functional similarity of ABP 959 and eculizumab in simulated serum models of aHUS and NMOSD

Pregnancy-triggered atypical hemolytic uremic syndrome (aHUS): a Global aHUS Registry analysis

Clinical efficacy and safety of switching from eculizumab to ravulizumab in adult patients with aHUS– real-world data

The global aHUS registry: methodology and initial patient characteristics

The global aHUS registry: methodology and initial patient characteristics

Ahus

Ahus

Charakterisierung von Patienten mit atypischem hämolytisch-urämischen Syndrom (aHUS) in Deutschland : Daten aus dem globalen aHUS-Register

Outcomes following second allogeneic stem cell transplant for disease relapse after T cell depleted transplant correlate with remission status and remission duration after the first transplant

Treating C3 glomerulopathy with eculizumab

Treating C3 glomerulopathy with eculizumab

Eculizumab treatment in paediatric patients diagnosed with aHUS after haematopoietic stem cell transplantation: a HSCT-TMA case series from Japanese aHUS post-marketing surveillance

Functional similarity of ABP 959 and eculizumab in simulated serum models of aHUS and NMOSD

Pregnancy-triggered atypical hemolytic uremic syndrome (aHUS): a Global aHUS Registry analysis

Clinical efficacy and safety of switching from eculizumab to ravulizumab in adult patients with aHUS– real-world data

The global aHUS registry: methodology and initial patient characteristics

The global aHUS registry: methodology and initial patient characteristics

Ahus

Ahus

Charakterisierung von Patienten mit atypischem hämolytisch-urämischen Syndrom (aHUS) in Deutschland : Daten aus dem globalen aHUS-Register

Outcomes following second allogeneic stem cell transplant for disease relapse after T cell depleted transplant correlate with remission status and remission duration after the first transplant

Treating C3 glomerulopathy with eculizumab

Treating C3 glomerulopathy with eculizumab

Eculizumab treatment in paediatric patients diagnosed with aHUS after haematopoietic stem cell transplantation: a HSCT-TMA case series from Japanese aHUS post-marketing surveillance

Functional similarity of ABP 959 and eculizumab in simulated serum models of aHUS and NMOSD

Pregnancy-triggered atypical hemolytic uremic syndrome (aHUS): a Global aHUS Registry analysis

Clinical efficacy and safety of switching from eculizumab to ravulizumab in adult patients with aHUS– real-world data

The global aHUS registry: methodology and initial patient characteristics

The global aHUS registry: methodology and initial patient characteristics

Ahus

Ahus

Charakterisierung von Patienten mit atypischem hämolytisch-urämischen Syndrom (aHUS) in Deutschland : Daten aus dem globalen aHUS-Register

Outcomes following second allogeneic stem cell transplant for disease relapse after T cell depleted transplant correlate with remission status and remission duration after the first transplant

Treating C3 glomerulopathy with eculizumab

Treating C3 glomerulopathy with eculizumab

Related objects

Reset password